Opendata, web and dolomites

Smartscope-X SIGNED

Affordable, accessible and automatic screening solution for diabetic retinopathy

Total Cost €


EC-Contrib. €






Project "Smartscope-X" data sheet

The following table provides information about the project.


Organization address
city: OULU
postcode: 90230

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Project website
 Total cost 2˙817˙050 €
 EC max contribution 1˙971˙935 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2020-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OPTOMED OY FI (OULU) coordinator 1˙971˙935.00


 Project objective

Diabetes is a growing global health concern, affecting 422M people today and the number is projected to rise to 642M by 2040. Over 30 % of diabetics develop a vision-threatening complication called diabetic retinopathy (DR), which is the most frequent cause of preventable blindness in working-aged adults. DR is diagnosed from retinal images traditionally graded by an ophthalmologist. Regular eye screenings are the only effective way to detect disease at early stage to prevent visual impairment or blindness. Hence, globally more than 1 billion screenings would be needed annually. Time, cost and resource efficient screening methods are needed to reach all diabetics. Finnish Optomed Oy (Ltd.) combines the precision of their handheld fundus camera with an automatic DR grading to establish Smartscope-X solution. Smartscope-X consists of three main components: a low-cost handheld fundus camera, an automated screening algorithm and cloud service for fundus images. With this unique combination, Optomed’s vision is to bring affordable, accessible and automatic DR screening available for all diabetics. In this project, the key ambition is to validate and commercialise Smartscope-X solution. The project has four objectives: (1) DR algorithm is integrated into Optomed fundus camera and Optomed Cloud service is developed, (2) clinical validations are conducted, (3) piloting and commercialisation of the Smartscope-X, with necessary approvals, (4) to establish a data safety and storage system. Smartscope-X will have a significant impact on visual impairment and blindness prevention in Europe and globally. Today, significant equipment investment and an experienced grader or ophthalmologist are needed. Hence, DR screening availability is limited. Smartscope-X user can be trained to use the solution in 1-2 hours. Screening with Smartscope-X will cost 10 % of current. Therefore, DR screening becomes available to new customers such as endocrinology clinics and even primary care.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SMARTSCOPE-X" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SMARTSCOPE-X" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)


CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More